Does CANDESARTAN Cause Peripheral venous disease? 549 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 549 reports of Peripheral venous disease have been filed in association with CANDESARTAN. This represents 6.1% of all adverse event reports for CANDESARTAN.
549
Reports of Peripheral venous disease with CANDESARTAN
6.1%
of all CANDESARTAN reports
549
Deaths
464
Hospitalizations
How Dangerous Is Peripheral venous disease From CANDESARTAN?
Of the 549 reports, 549 (100.0%) resulted in death, 464 (84.5%) required hospitalization, and 479 (87.2%) were considered life-threatening.
Is Peripheral venous disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANDESARTAN. However, 549 reports have been filed with the FAERS database.
What Other Side Effects Does CANDESARTAN Cause?
Off label use (1,911)
Fatigue (1,468)
Dyspnoea (1,456)
Pain (1,455)
Drug ineffective (1,428)
Headache (1,371)
Nausea (1,282)
Dizziness (1,237)
Vomiting (1,202)
Diarrhoea (1,145)
What Other Drugs Cause Peripheral venous disease?
RITUXIMAB (1,281)
ADALIMUMAB (1,249)
METHOTREXATE (1,246)
SECUKINUMAB (1,186)
ABATACEPT (1,168)
DICLOFENAC (1,168)
LEFLUNOMIDE (1,154)
TOCILIZUMAB (1,137)
PREDNISONE (1,101)
ALENDRONATE (1,097)
Which CANDESARTAN Alternatives Have Lower Peripheral venous disease Risk?
CANDESARTAN vs CANDESARTAN CILEXETIL
CANDESARTAN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE
CANDESARTAN vs CANGRELOR
CANDESARTAN vs CANIS LUPUS FAMILIARIS SKIN
CANDESARTAN vs CANNABIDIOL